Related Experiment Video
Updated: May 29, 2026

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity
Published on: January 29, 2018
MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity
Maren H Stindt1, Stephanie Carter, Arnaud M Vigneron
1The Beatson Institute for Cancer Research; Glasgow, UK.
Abstract:
The tumor suppressor p53 is extensively regulated by post-translational modification, including modification by the small ubiquitin-related modifier SUMO. We show here that MDM2, previously shown to promote ubiquitin, Nedd8 and SUMO-1 modification of p53, can also enhance conjugation of endogenous SUMO-2/3 to p53. Sumoylation activity requires p53-MDM2 binding but does not depend on an intact RING finger. Both ARF and L11 can promote SUMO-2/3 conjugation of p53. However, unlike the previously described SUMO-1 conjugation of p53 by an MDM2-ARF complex, this activity does not depend on the ability of MDM2 to relocalize to the nucleolus. Interestingly, the SUMO consensus is not conserved in mouse p53, which is therefore not modified by SUMO-2/3. Finally, we show that conjugation of SUMO-2/3 to p53 correlates with a reduction of both activation and repression of a subset of p53-target genes.
Insights
The tumor suppressor p53 undergoes SUMO-2/3 modification, enhanced by MDM2, ARF, and L11. This modification impacts p53-target gene activity.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- The tumor suppressor p53 is a critical regulator of cellular responses to stress.
- Post-translational modifications, including SUMOylation, play a significant role in p53 regulation.
- MDM2 is a known regulator of p53, primarily involved in its ubiquitylation.
Purpose of the Study:
- To investigate the role of MDM2 in SUMO-2/3 conjugation of p53.
- To determine the factors that promote SUMO-2/3 modification of p53.
- To elucidate the functional consequences of SUMO-2/3 conjugation on p53 activity.
Main Methods:
- Western blotting to detect SUMO-2/3 conjugation to p53.
- Co-immunoprecipitation assays to study protein interactions.
- Analysis of p53-target gene expression.
Main Results:
- MDM2 enhances the conjugation of endogenous SUMO-2/3 to p53.
- p53-MDM2 binding is required for SUMO-2/3 conjugation, independent of the RING finger domain.
- ARF and L11 also promote SUMO-2/3 conjugation of p53.
- SUMO-2/3 conjugation of p53 does not require MDM2 relocalization to the nucleolus.
- Mouse p53, lacking the SUMO consensus, is not modified by SUMO-2/3.
- SUMO-2/3 conjugation of p53 correlates with reduced activation and repression of target genes.
Conclusions:
- MDM2, ARF, and L11 are key regulators of p53 SUMO-2/3 modification.
- SUMO-2/3 conjugation of p53 influences the transcriptional activity of a subset of its target genes.
- This study reveals a novel regulatory mechanism for p53 involving SUMO-2/3 conjugation.
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Negative Regulator Molecules

